(Q35069686)
Statements
1 reference
DURATION-2: efficacy and safety of switching from maximum daily sitagliptin or pioglitazone to once-weekly exenatide (English)
1 reference
C Wysham
1 reference
R Bergenstal
1 reference
J Malloy
1 reference
P Yan
1 reference
B Walsh
1 reference
J Malone
1 reference
K Taylor
1 reference
1 June 2011
1 reference
1 reference
28
1 reference
6
1 reference
705-714
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference